Completed NA INTERVENTIONAL 3-arm NCT03713697

Self-Collection and Human Papillomavirus (HPV) Testing in Unscreened Women: a Feasibility Study in Brazil (HPV)

Self-Collection and HPV Testing in Unscreened Women: a Feasibility Study in Brazil

Sponsor: National Cancer Institute (NCI)

Interventions Choice Pap testing Self-collection for HPV testing

Updated 4 times since 2018 Last updated: Oct 19, 2018 Started: Jan 1, 2016 Primary completion: Nov 30, 2016 Completion: Jan 20, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cervical Cancer and is currently completed. National Cancer Institute (NCI) leads this study, which shows 4 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2018 — Jan 2021 [monthly]

Completed NA

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
University of Alabama at Birmingham

Data source: University of Alabama at Birmingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maringá, Brazil